J. Kurpewski

发表

Detection of Fastidious Vaginal Bacteria in Women with HIV Infection and Bacterial Vaginosis

A. Caliendo, C. Mitchell, D. Fredricks, 2009, Infectious diseases in obstetrics and gynecology.

Modest but Variable Effect of Rifampin on Steady-State Plasma Pharmacokinetics of Efavirenz in Healthy African-American and Caucasian Volunteers

D. Greenblatt, K. Tashima, A. Kashuba, 2011, Antimicrobial Agents and Chemotherapy.

Prevalence and persistence of nonnucleoside reverse transcriptase inhibitor mutations in the female genital tract.

A. Caliendo, S. Cu-Uvin, B. Ramratnam, 2005, Journal of acquired immune deficiency syndromes.

Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.

J. Hogan, A. Caliendo, S. Cu-Uvin, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of First-Line Antituberculosis Drugs Using WHO Revised Dosage in Children With Tuberculosis With and Without HIV Coinfection.

Hongmei Yang, D. Ansong, Anima M. Sarfo, 2016, Journal of the Pediatric Infectious Diseases Society.

Evaluation of Performance Characteristics of the Aptima HIV-1 Quant Dx Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 in Plasma and Cervicovaginal Lavage Samples

A. Caliendo, S. Cu-Uvin, J. Kurpewski, 2016, Journal of Clinical Microbiology.

Genital tract leukocytes and shedding of genital HIV type 1 RNA.

A. Caliendo, K. Mayer, S. Cu-Uvin, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load

J. Hogan, A. Caliendo, R. D’Aquila, 2010, AIDS.

Association Between Paired Plasma and Cervicovaginal Lavage Fluid HIV-1 RNA Levels During 36 Months

J. Hogan, A. Caliendo, K. Mayer, 2006, Journal of acquired immune deficiency syndromes.

Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.

R. D’Aquila, R. Kantor, S. Cu-Uvin, 2013, Journal of women's health.

Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasma.

K. Tashima, T. Flanigan, P. Skolnik, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors Associated with Variability in Rifampin Plasma Pharmacokinetics and the Relationship between Rifampin Concentrations and Induction of Efavirenz Clearance

K. Tashima, Hongmei Yang, A. Kwara, 2014, Pharmacotherapy.

Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavir.

K. Tashima, A. Caliendo, T. Flanigan, 2006, AIDS.

Effect of treatment of asymptomatic bacterial vaginosis on HIV-1 shedding in the genital tract among women on antiretroviral therapy: a pilot study.

A. Caliendo, S. Cu-Uvin, Carla C Moreira, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of HSV-2 Suppressive Therapy on Genital Tract HIV-1 RNA Shedding among Women on HAART: A Pilot Randomized Controlled Trial

A. Caliendo, S. Cu-Uvin, A. Rana, 2012, Infectious diseases in obstetrics and gynecology.

T2 Magnetic Resonance for Fungal Diagnosis.

E. Mylonakis, J. Kurpewski, F. Zervou, 2017, Methods in molecular biology.